Literature DB >> 7889276

Beta-adrenoceptors mediate inhibition of [3H]-acetylcholine release from the isolated rat and guinea-pig trachea: role of the airway mucosa and prostaglandins.

I Wessler1, T Reinheimer, G Brunn, G P Anderson, J Maclagan, K Racké.   

Abstract

1. Rat or guinea pig isolated tracheae were labelled with [3H]-choline to measure evoked tritium outflow, which reflects neuronal release of [3H]-acetylcholine. Tritium outflow was evoked either by electrical stimulation of the extrinsic vagal nerve (rat tracheae) or by 27 mM potassium (guinea pig tracheae). 2. In rat tracheae isoprenaline (0.01, 0.1 microM) inhibited evoked [3H]-acetylcholine release, whereas beta 2-adrenoceptor-selective agonists (fenoterol, formoterol, salbutamol) were ineffective. 3. The inhibitory effect of isoprenaline was abolished under the following conditions: (i) presence of propranolol (1 microM) or of the beta 1-selective antagonist CGP 20712 A (0.1 microM); (ii) removal of the mucosa at the start of the experiments; (iii) blockade of cyclooxygenase activity by 3 microM indomethacin. 4. In rat isolated tracheae prelabelled with [3H]-arachidonic acid, isoprenaline (0.1 microM) but not formoterol (0.01 microM) enhanced the outflow of [3H]-prostaglandins (PGD2, PGE2). This effect was blocked by 0.1 microM CGP 20712 A. 5. In guinea pig tracheae electrical stimulation of the extrinsic vagal nerve did not cause a constant release of [3H]-acetylcholine, but 27 mM potassium elicited a reproducible release of [3H]-acetylcholine. In this species both isoprenaline (0.1 microM) and formoterol (0.01 microM) inhibited evoked [3H]-acetylcholine release. Inhibition was abolished under the following conditions: (i) presence of propranolol (1 microM) or of the beta 2-selective antagonist ICI 118551 (0.3 microM); (ii) removal of the mucosa at the start of the experiments; (iii) blockade of cyclooxygenase activity by 3 microM indomethacin. 6. In conclusion, the present experiments have demonstrated that activation of beta-adrenoceptors localized in the mucosa mediates inhibition of [3H]-acetylcholine release from the neuroeffector junctions of the pulmonary, parasympathetic nerves most probably by the liberation of inhibitory prostaglandins from the airway mucosa. The adrenoceptor subtype involved differs in rat (beta 1 subtype) and guinea pig (beta 2 subtype) airways.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7889276      PMCID: PMC1510489          DOI: 10.1111/j.1476-5381.1994.tb17128.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  Coexistence of beta1 and beta2 adrenoceptors in mammalian lung: evidence from direct binding studies.

Authors:  E L Rugg; D B Barnett; S R Nahorski
Journal:  Mol Pharmacol       Date:  1978-11       Impact factor: 4.436

2.  Inhibitory effects of catecholamine in isolated canine bronchial smooth muscle.

Authors:  P A Vermeire; P M Vanhoutte
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1979-04

3.  Ultrastructural and fluorescence histochemical studies on the innervation of the tracheo bronchial muscle of normal cats and cats treated with 6-hydroxydopamine.

Authors:  D G Silva; G Ross
Journal:  J Ultrastruct Res       Date:  1974-06

4.  Some statistical methods useful in circulation research.

Authors:  S Wallenstein; C L Zucker; J L Fleiss
Journal:  Circ Res       Date:  1980-07       Impact factor: 17.367

5.  Ultrastructural study of guinea pig tracheal smooth muscle and its innervation.

Authors:  T R Jones; M S Kannan; E E Daniel
Journal:  Can J Physiol Pharmacol       Date:  1980-08       Impact factor: 2.273

6.  Innervation of intrapulmonary airway smooth muscle of the dog, monkey and baboon.

Authors:  D S Knight; A L Hyman; P J Kadowitz
Journal:  J Auton Nerv Syst       Date:  1981-02

7.  Inhibition by acetylcholine of the stimulation-evoked release of [3H]acetylcholine from the guinea-pig myenteric plexus.

Authors:  H Kilbinger; I Wessler
Journal:  Neuroscience       Date:  1980       Impact factor: 3.590

8.  Inhibition of cholinergic neurotransmission in human airways by beta 2-adrenoceptors.

Authors:  K J Rhoden; L A Meldrum; P J Barnes
Journal:  J Appl Physiol (1985)       Date:  1988-08

9.  Selective distribution of beta- and alpha 1-adrenoceptors in rat lung visualized by autoradiography.

Authors:  Q F Xue; R Maurer; G Engel
Journal:  Arch Int Pharmacodyn Ther       Date:  1983-12

10.  The role of phospholipase in beta-agonist-induced down regulation in guinea pig lungs.

Authors:  K Suzuki; S Sugiyama; K Takagi; T Satake; T Ozawa
Journal:  Biochem Med Metab Biol       Date:  1987-04
View more
  6 in total

1.  Characterization of the effects of cannabinoids on guinea-pig tracheal smooth muscle tone: role in the modulation of acetylcholine release from parasympathetic nerves.

Authors:  L Spicuzza; E B Haddad; M Birrell; A Ling; D Clarke; P Venkatesan; P J Barnes; M G Belvisi
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

2.  Mucosa-dependent muscarinic liberation of prostaglandins from rat isolated trachea.

Authors:  G Brunn; I Wessler; K Racké
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

3.  E-ring 8-isoprostanes inhibit ACh release from parasympathetic nerves innervating guinea-pig trachea through agonism of prostanoid receptors of the EP3-subtype.

Authors:  Deborah L Clarke; Mark A Giembycz; Hema J Patel; Maria G Belvisi
Journal:  Br J Pharmacol       Date:  2004-01-26       Impact factor: 8.739

4.  Paradoxical facilitation of acetylcholine release from parasympathetic nerves innervating guinea-pig trachea by isoprenaline.

Authors:  M G Belvisi; H J Patel; T Takahashi; P J Barnes; M A Giembycz
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

Review 5.  Beta-Adrenergic Agonists.

Authors:  Giovanni Barisione; Michele Baroffio; Emanuele Crimi; Vito Brusasco
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-30

Review 6.  The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease.

Authors:  Philippa R Dale; Hana Cernecka; Martina Schmidt; Mark R Dowling; Steven J Charlton; Michael P Pieper; Martin C Michel
Journal:  Curr Opin Pharmacol       Date:  2014-03-27       Impact factor: 5.547

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.